Clover Health Investments (CLOV) Regains Nasdaq Compliance

Clover Health Investments, Corp. (NASDAQ: CLOV) today announced that it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1).

As previously disclosed, the Company received a written notice from Nasdaq on April 2, 2024, notifying the Company that it had failed to meet the $1.00 per share minimum bid price requirement as part of the Nasdaq Global Select Market’s listing standards.

To regain compliance with the Listing Rule, the Company’s Class A Common Stock was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days, which was achieved on June 25, 2024. Nasdaq has stated that this matter is now closed.

To learn more about Clover Health, visit: investors.cloverhealth.com.

You May Also Be Interested In

• Cantor Fitzgerald Starts Tempus AI Inc (TEM) at Overweight
• Nextdoor updates local business search with AI tools and new hub
• Brad Hively to exit Starling Oncology board at 2027 annual meeting